US Healthcare: Sky-High Costs, Deadly Delays

The United States leads industrialized nations in health spending but lags significantly in health outcomes. Projections estimate Americans will spend $5.6 trillion on healthcare in 2025, a figure expected to climb.

Despite these costs, issues like fragmented insurance and treatment delays leave patients at risk. Rebecca Payette's experience exemplifies this, as her stage 4 cancer diagnosis was delayed after an initial PET scan was denied by her insurer.

In 2023, nearly one in five in-network claims and 37% of out-of-network claims were rejected. Marketplace insurance users reported higher denial rates than those with Medicare or Medicaid.

Reasons for denial vary, including benefit limits or procedures deemed experimental. Insurers often require 'peer to peer' reviews, which can be challenging. These denials can result in patients facing substantial out-of-pocket costs.

Patients earning less than $30,000 annually are significantly more likely to have preventative care claims denied. Experiencing a denial can be stressful, but patients have the right to appeal decisions and file complaints with state commissioners.

Building an emergency savings fund is also vital. Medical bills are a leading cause of bankruptcy in the US, and financial preparedness can ensure access to necessary treatment amidst rising denial rates.